Clinical and Biological Status of 17 Patients With EBV-HLH
Sex | 4M, 13F |
Median age (range) at diagnosis | 4 yr (0.8-12.3) |
Family history of HLH | None |
Initial clinical presentation (no. of cases) | |
Persistent fever (≥38.5°C) | 17 |
Hepatosplenomegaly | 15 |
Coagulopathy | 13 |
CNS symptoms | 3 |
Lymphadenopathy | 10 |
Jaundice | 9 |
Pleural effusion | 6 |
Initial biological presentation (no. of cases)* | |
Cytopenia | 17 |
Hypertriglyceridemia | 12 |
Hypofibrinogenemia | 13 |
Serum ferritin >1,000 ng/mL | 12 |
Serum LDH >1,000 IU/L | 16 |
Specimen positive for EBV-DNA | 17 |
Sex | 4M, 13F |
Median age (range) at diagnosis | 4 yr (0.8-12.3) |
Family history of HLH | None |
Initial clinical presentation (no. of cases) | |
Persistent fever (≥38.5°C) | 17 |
Hepatosplenomegaly | 15 |
Coagulopathy | 13 |
CNS symptoms | 3 |
Lymphadenopathy | 10 |
Jaundice | 9 |
Pleural effusion | 6 |
Initial biological presentation (no. of cases)* | |
Cytopenia | 17 |
Hypertriglyceridemia | 12 |
Hypofibrinogenemia | 13 |
Serum ferritin >1,000 ng/mL | 12 |
Serum LDH >1,000 IU/L | 16 |
Specimen positive for EBV-DNA | 17 |
Abbreviations: EBV-HLH, Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis; LDH, lactate dehydrogenase.
Normal laboratory values are reported in the text.